Chemoinformaics analysis of 2,3,5-Tri-O-methyl-L-arabinose
| Molecular Weight | 192.211 | nRot | 7 |
| Heavy Atom Molecular Weight | 176.083 | nRig | 1 |
| Exact Molecular Weight | 192.1 | nRing | 0 |
| Solubility: LogS | 0.589 | nHRing | 0 |
| Solubility: LogP | -0.98 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 28.0387 |
| nHD | 1 | BPOL | 22.1273 |
| QED | 0.536 |
| Synth | 4.029 |
| Natural Product Likeliness | 1.424 |
| NR-PPAR-gamma | 0.024 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.065 |
| HIA | 0.227 |
| CACO-2 | -4.687 |
| MDCK | 0.0000819 |
| BBB | 0.109 |
| PPB | 0.254151 |
| VDSS | 0.518 |
| FU | 0.774118 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.772 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.459 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.021 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.128 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.253 |
| CL | 6.098 |
| T12 | 0.547 |
| hERG | 0.075 |
| Ames | 0.238 |
| ROA | 0.011 |
| SkinSen | 0.799 |
| Carcinogencity | 0.036 |
| EI | 0.941 |
| Respiratory | 0.028 |
| NR-Aromatase | 0.214 |
| Antiviral | No |
| Prediction | 0.927205 |